List of Levaquin drug patents
Levaquin is owned by Janssen Pharms.
Levaquin contains Levofloxacin.
Levaquin has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Levaquin are:
- US6806256
- US6806256*PED
Levaquin was authorised for market use on 21 October, 2004.
Levaquin is available in solution;oral dosage forms.
The generics of Levaquin are possible to be released after 26 August, 2022.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6806256 | JANSSEN PHARMS | Taste masked liquid pharmaceutical compositions |
Feb, 2022
(1 year, 3 months ago) | |
|
US6806256 (Pediatric) | JANSSEN PHARMS | Taste masked liquid pharmaceutical compositions |
Aug, 2022
(9 months ago) | |
Do you want to check out LEVAQUIN patents from before 2022?
Drugs and Companies using LEVOFLOXACIN ingredient
Market Authorisation Date: 21 October, 2004
Treatment: NA
Dosage: SOLUTION;ORAL
How can I launch a generic of LEVAQUIN before it's patent expiration?
More Information on Dosage
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic